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Abstract
A 350 bp amplicon, obtained by PCR-select subtractive hybridization from RNA derived from mesenteric lymph nodes
 .MLN cells from mice pre-immunized with allogeneic lymphocytes 36hrs prior to receiving donor-specific skin grafts, and
showing )98% homology with a published sequence for the rat MRC OX-2 gene, was used as a hybridization probe to
screen a cDNA library constructed from adult mouse MLN treated in the same fashion. Several clones were identified
which, on DNA sequence analysis, predicted a 218 amino acid protein showing significant homology with the rat and
human MRC OX-2 gene product. q 1997 Elsevier Science B.V.
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The MRC OX-2 antigen in rat was described as a
41 Kd–47 Kd glycoprotein which is expressed on the
cell surface of thymocytes, follicular dendritic cells
w xand endothelium, B cells and neuronal cells 1,2 .
Differences in apparent size of the molecule in differ-
ent tissues is probably a function of differential
w xglycosylation 3 . The function of the molecule is
unknown, but DNA and amino acid sequence analy-
sis shows it has a high degree of homology to
w xmolecules of the immunoglobulin gene family 4 ,
which includes molecules important in lymphocyte
antigen recognition and cell-cell interaction e.g. CD4,
.CD8, ICAMs, VCAMs , as well as adhesion receptor
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 . w xmolecules NCAMs in the nervous system 5 . Mem-
bers of the immunoglobulin superfamily are distinct
from other molecules of the integrin and selectin
families, which, at least within the immune system,
w xalso seem to play critical role in cell recognition 6 ,
w xmigration 7 and even development of the lympho-
cyte recognition repertoire by regulating intra-thymic
. w xselection events 8 . It has become increasingly evi-
dent that molecules of these different families play an
w ximportant role in human disease 9 .
A key role for a number of cell surface molecules
in the integrinrimmunoglobulin superfamily seems
to lie in the provision of auxiliary signals to lympho-
cytes activated also by engagement of antigen-specific
receptors. Within the T cell arm, these co-stimulatory
molecules can regulate production of cytokines,
themselves critical for cell:cell signaling in the im-
w xmune system 10,11 . Regulation of cytokine produc-
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Fig. 1. Comparison of the cDNA sequence rat, mouse and human MRC OX-2.
tion following antigen stimulation is important in
immunity to infectious organisms, in the development
w xof auoimmunity, and in transplantation 12–14 . We
have proposed that pre-transplant portal venous infu-
sion of antigen-specific dendritic cells induces
w xdown-regulation of graft rejection in mice 15 . Work
in preparation from our laboratory 2 suggests that
these effects are associated with increased expression
2  .R.M. Gorczynski, Z. Chen, X.M. Fu, and H. Zeng 1997 :
submitted for publication.
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of a gene product homologous with the rat MRC
OX-2 antigen. This report describes the nucleotide
and deduced amino acid sequence of murine MRC
OX-2.
We constructed a cDNA library from MLN cells
derived from adult C3H mice, preimmunized 5 days
earlier with 10=106 allogeneic B10.BR bone mar-
row-derived dendritic cells allogeneic cells by the
 .portal venous pv route, using a Cap Finder PCR
 .cDNA library construction kit Clontech . We had
previously isolated, using a PCR-Select cDNA sub-
 .traction hybridization kit Clontech and RNAs ob-
Fig. 2. Comparison of the deduced protein sequence of rat, mouse and human MRC OX-2.
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tained from pooled MLN of mice immunized by the
 .pv route or via the lateral tail vein iv , a 350 bp
amplicon which showed over 98% homology with
the 3X untranslated region of rat MRC OX-2 cDNA.
Northern blot analysis confirmed that this amplicon
detected a differentially expressed product in RNAs
prepared from iv vs pv immunized mice Gorczynski
.et aly in preparation . This amplicon was used to
screen 5=105 clones of the amplified library. The
sequences of cDNA clones were established with an
Applied Biosystems 377 Automated Sequencer, uti-
lizing the Dye Terminator Cycle Sequencing method
 .Applied Biosystems, Foster City, CA . The nu-
cleotide sequence reported in this paper has been
submitted to the GenBankrEMBL Data Bank with
accession number AF004023.
The cDNA shown in Fig. 1 has an open reading
frame of 837 base pairs, and a deduced amino acid
 .sequence Fig. 2 of 248 amino acids, of which 30
represent a cleaved leader sequence. The predicted
molecular weight of this, and the equivalent molecules
in rat and human, is approximately 25 kDa. The
measured molecular weight in rat thymocytes, where
the molecule is highly gylcosylated, is 47 kDa3.
The murine MRC OX-2 shows some 92% and
77% homology overall at the amino acid level with
equivalent molecules in rat or human respectively. As
noted for the rat molecule, the sequence from aa
203–229 seems likely to represent a membrane span-
 .ning domain highly hydrophobic region , while the
region from 229 to 248 is likely the intracytoplasmic
region, with a stretch of highly basic residues imme-
diately C-terminal to position 229. Homology in the
combined transmembrane and C-terminal regions with
rat and human shows some 98% and 85% similarity
respectively. As predicted from membership in the Ig
supergene family, there are a number of conserved
Cys residues forming the disulphide bonds between
b-strands of Ig-like domains, 21 and 91; 130 and
.184 respectively ; residue 91 was previously found to
be the most highly conserved among members of the
w ximmunoglobulin superfamily 4 . Homology between
the N-terminal Ig-domain with rat and human, versus
the next Ig-domain, is 88% and 82%, or 97% and
73% respectively. This relative concentration in vari-
ability between rat and mouse in the V-terminal
Ig-domain may be more understandable when the
ligand specificity for the molecules in these species is
clarified. Note that the presumed extracellular portion
 .of the molecule 1-202 contains a number of sites
for N-glycosylation which are preserved across
 .species 44, 65, 73, 80, 94, 127, 130 and 151 . This
was previously reported for the rat cDNA sequence,
and inferred from the measured size of the expressed
w xmaterial in rat thymocytes 3 .
The intracytoplasmic region of the molecules has
no sequence identity with known signaling kinases,
nor does it have the well-described consensus se-
quence for the ‘‘immunoreceptor tyrosine activation
 . w xmotif’’ ITAM: DXXYXXLXXXXXXXYDXL 16 .
In addition, it lacks typical SH2 or SH3 domains to
serve as ‘‘docking sites’’ for adapter molecules which
might in turn co-opt other protein kinases in an
w xactivation cascade 17 . Accordingly the ligand-bind-
ing activity of the extracellular domains presumably
represent the biologically important region of the
molecule. Some possible functions attributable to lig-
and interaction with OX-2 can be inferred from other
data in the literature. A homologous molecule, Ng-
CAM, has been reported to bind a protein–tyrosine
phosphatase via N-linked oligosaccharide residues
w x18 , and protein tyrosine phosphatases are known to
w xplay a key regulatory role in immune responses 19 .
More recently ALCAM, another ‘‘adhesion
molecule’’ member of the Ig superfamily, the gene
for which is located close to that for OX-2 on
w xchromosome 3 in humans 20 , has been shown to
bind CD6 a member of the scavenger receptor cys-
. w xtein rich family, SRCR 21 , and antibodies to CD6
may themselves play a role in regulating immune
w xfunction 22 . Our current studies are designed to
characterize the biological ligand for OX-2.
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